Trial Profile
A prospective comparative clinical study to identify efficacy and safety of pitavastatin in patients with a metabolic syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Acronyms ProPit
- Sponsors JW Pharmaceutical
- 29 Mar 2012 Actual patient number (187) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.